List of Tables
Table 1. Global Central Nervous System Nanomedicines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Central Nervous System Nanomedicines Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Central Nervous System Nanomedicines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Central Nervous System Nanomedicines Sales (Units) of Key Manufacturers (2020-2025)
Table 5. Global Central Nervous System Nanomedicines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Central Nervous System Nanomedicines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Central Nervous System Nanomedicines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Central Nervous System Nanomedicines Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Central Nervous System Nanomedicines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Central Nervous System Nanomedicines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Central Nervous System Nanomedicines, Product Type & Application
Table 12. Global Key Manufacturers of Central Nervous System Nanomedicines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Central Nervous System Nanomedicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Nanomedicines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Central Nervous System Nanomedicines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Central Nervous System Nanomedicines Sales by Region (2020-2025) & (Units)
Table 18. Global Central Nervous System Nanomedicines Sales Market Share by Region (2020-2025)
Table 19. Global Central Nervous System Nanomedicines Sales by Region (2026-2031) & (Units)
Table 20. Global Central Nervous System Nanomedicines Sales Market Share by Region (2026-2031)
Table 21. Global Central Nervous System Nanomedicines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Central Nervous System Nanomedicines Revenue Market Share by Region (2020-2025)
Table 23. Global Central Nervous System Nanomedicines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Central Nervous System Nanomedicines Revenue Market Share by Region (2026-2031)
Table 25. North America Central Nervous System Nanomedicines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Central Nervous System Nanomedicines Sales by Country (2020-2025) & (Units)
Table 27. North America Central Nervous System Nanomedicines Sales by Country (2026-2031) & (Units)
Table 28. North America Central Nervous System Nanomedicines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Central Nervous System Nanomedicines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Central Nervous System Nanomedicines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Central Nervous System Nanomedicines Sales by Country (2020-2025) & (Units)
Table 32. Europe Central Nervous System Nanomedicines Sales by Country (2026-2031) & (Units)
Table 33. Europe Central Nervous System Nanomedicines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Central Nervous System Nanomedicines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Central Nervous System Nanomedicines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Central Nervous System Nanomedicines Sales by Region (2020-2025) & (Units)
Table 37. Asia Pacific Central Nervous System Nanomedicines Sales by Region (2026-2031) & (Units)
Table 38. Asia Pacific Central Nervous System Nanomedicines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Central Nervous System Nanomedicines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Central Nervous System Nanomedicines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Central Nervous System Nanomedicines Sales by Country (2020-2025) & (Units)
Table 42. Latin America Central Nervous System Nanomedicines Sales by Country (2026-2031) & (Units)
Table 43. Latin America Central Nervous System Nanomedicines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Central Nervous System Nanomedicines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Central Nervous System Nanomedicines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Central Nervous System Nanomedicines Sales by Country (2020-2025) & (Units)
Table 47. Middle East and Africa Central Nervous System Nanomedicines Sales by Country (2026-2031) & (Units)
Table 48. Middle East and Africa Central Nervous System Nanomedicines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Central Nervous System Nanomedicines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Central Nervous System Nanomedicines Sales (Units) by Type (2020-2025)
Table 51. Global Central Nervous System Nanomedicines Sales (Units) by Type (2026-2031)
Table 52. Global Central Nervous System Nanomedicines Sales Market Share by Type (2020-2025)
Table 53. Global Central Nervous System Nanomedicines Sales Market Share by Type (2026-2031)
Table 54. Global Central Nervous System Nanomedicines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Central Nervous System Nanomedicines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Central Nervous System Nanomedicines Revenue Market Share by Type (2020-2025)
Table 57. Global Central Nervous System Nanomedicines Revenue Market Share by Type (2026-2031)
Table 58. Global Central Nervous System Nanomedicines Price (US$/Unit) by Type (2020-2025)
Table 59. Global Central Nervous System Nanomedicines Price (US$/Unit) by Type (2026-2031)
Table 60. Global Central Nervous System Nanomedicines Sales (Units) by Application (2020-2025)
Table 61. Global Central Nervous System Nanomedicines Sales (Units) by Application (2026-2031)
Table 62. Global Central Nervous System Nanomedicines Sales Market Share by Application (2020-2025)
Table 63. Global Central Nervous System Nanomedicines Sales Market Share by Application (2026-2031)
Table 64. Global Central Nervous System Nanomedicines Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Central Nervous System Nanomedicines Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Central Nervous System Nanomedicines Revenue Market Share by Application (2020-2025)
Table 67. Global Central Nervous System Nanomedicines Revenue Market Share by Application (2026-2031)
Table 68. Global Central Nervous System Nanomedicines Price (US$/Unit) by Application (2020-2025)
Table 69. Global Central Nervous System Nanomedicines Price (US$/Unit) by Application (2026-2031)
Table 70. IntraCellular Therapies Company Information
Table 71. IntraCellular Therapies Description and Business Overview
Table 72. IntraCellular Therapies Central Nervous System Nanomedicines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. IntraCellular Therapies Central Nervous System Nanomedicines Product
Table 74. IntraCellular Therapies Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Central Nervous System Nanomedicines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Pfizer Central Nervous System Nanomedicines Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Central Nervous System Nanomedicines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Novartis Central Nervous System Nanomedicines Product
Table 84. Novartis Recent Developments/Updates
Table 85. Aldeyra Therapeutics Company Information
Table 86. Aldeyra Therapeutics Description and Business Overview
Table 87. Aldeyra Therapeutics Central Nervous System Nanomedicines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Aldeyra Therapeutics Central Nervous System Nanomedicines Product
Table 89. Aldeyra Therapeutics Recent Developments/Updates
Table 90. Biogen Company Information
Table 91. Biogen Description and Business Overview
Table 92. Biogen Central Nervous System Nanomedicines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Biogen Central Nervous System Nanomedicines Product
Table 94. Biogen Recent Developments/Updates
Table 95. LivaNova Company Information
Table 96. LivaNova Description and Business Overview
Table 97. LivaNova Central Nervous System Nanomedicines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. LivaNova Central Nervous System Nanomedicines Product
Table 99. LivaNova Recent Developments/Updates
Table 100. AbbVie Company Information
Table 101. AbbVie Description and Business Overview
Table 102. AbbVie Central Nervous System Nanomedicines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. AbbVie Central Nervous System Nanomedicines Product
Table 104. AbbVie Recent Developments/Updates
Table 105. Johnson And Johnson Company Information
Table 106. Johnson And Johnson Description and Business Overview
Table 107. Johnson And Johnson Central Nervous System Nanomedicines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Johnson And Johnson Central Nervous System Nanomedicines Product
Table 109. Johnson And Johnson Recent Developments/Updates
Table 110. NantKwest Company Information
Table 111. NantKwest Description and Business Overview
Table 112. NantKwest Central Nervous System Nanomedicines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. NantKwest Central Nervous System Nanomedicines Product
Table 114. NantKwest Recent Developments/Updates
Table 115. Baxter International Company Information
Table 116. Baxter International Description and Business Overview
Table 117. Baxter International Central Nervous System Nanomedicines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Baxter International Central Nervous System Nanomedicines Product
Table 119. Baxter International Recent Developments/Updates
Table 120. Rexahn Pharmaceuticals Company Information
Table 121. Rexahn Pharmaceuticals Description and Business Overview
Table 122. Rexahn Pharmaceuticals Central Nervous System Nanomedicines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Rexahn Pharmaceuticals Central Nervous System Nanomedicines Product
Table 124. Rexahn Pharmaceuticals Recent Developments/Updates
Table 125. Alcyone Therapeutics Company Information
Table 126. Alcyone Therapeutics Description and Business Overview
Table 127. Alcyone Therapeutics Central Nervous System Nanomedicines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Alcyone Therapeutics Central Nervous System Nanomedicines Product
Table 129. Alcyone Therapeutics Recent Developments/Updates
Table 130. Eli Lilly Company Information
Table 131. Eli Lilly Description and Business Overview
Table 132. Eli Lilly Central Nervous System Nanomedicines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Eli Lilly Central Nervous System Nanomedicines Product
Table 134. Eli Lilly Recent Developments/Updates
Table 135. Merck Company Information
Table 136. Merck Description and Business Overview
Table 137. Merck Central Nervous System Nanomedicines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Merck Central Nervous System Nanomedicines Product
Table 139. Merck Recent Developments/Updates
Table 140. Alkermes Company Information
Table 141. Alkermes Description and Business Overview
Table 142. Alkermes Central Nervous System Nanomedicines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Alkermes Central Nervous System Nanomedicines Product
Table 144. Alkermes Recent Developments/Updates
Table 145. Jiangsu Nhwa Pharmaceutical Company Information
Table 146. Jiangsu Nhwa Pharmaceutical Description and Business Overview
Table 147. Jiangsu Nhwa Pharmaceutical Central Nervous System Nanomedicines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Jiangsu Nhwa Pharmaceutical Central Nervous System Nanomedicines Product
Table 149. Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
Table 150. Luye Pharmaceutical Company Information
Table 151. Luye Pharmaceutical Description and Business Overview
Table 152. Luye Pharmaceutical Central Nervous System Nanomedicines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Luye Pharmaceutical Central Nervous System Nanomedicines Product
Table 154. Luye Pharmaceutical Recent Developments/Updates
Table 155. Jiangsu Hengrui Pharmaceuticals Company Information
Table 156. Jiangsu Hengrui Pharmaceuticals Description and Business Overview
Table 157. Jiangsu Hengrui Pharmaceuticals Central Nervous System Nanomedicines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Jiangsu Hengrui Pharmaceuticals Central Nervous System Nanomedicines Product
Table 159. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 160. Simcere Pharma Company Information
Table 161. Simcere Pharma Description and Business Overview
Table 162. Simcere Pharma Central Nervous System Nanomedicines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Simcere Pharma Central Nervous System Nanomedicines Product
Table 164. Simcere Pharma Recent Developments/Updates
Table 165. Qilu Pharmaceutical Company Information
Table 166. Qilu Pharmaceutical Description and Business Overview
Table 167. Qilu Pharmaceutical Central Nervous System Nanomedicines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Qilu Pharmaceutical Central Nervous System Nanomedicines Product
Table 169. Qilu Pharmaceutical Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Central Nervous System Nanomedicines Distributors List
Table 173. Central Nervous System Nanomedicines Customers List
Table 174. Central Nervous System Nanomedicines Market Trends
Table 175. Central Nervous System Nanomedicines Market Drivers
Table 176. Central Nervous System Nanomedicines Market Challenges
Table 177. Central Nervous System Nanomedicines Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Central Nervous System Nanomedicines
Figure 2. Global Central Nervous System Nanomedicines Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Central Nervous System Nanomedicines Market Share by Type: 2024 & 2031
Figure 4. Polymer Nanoparticles Product Picture
Figure 5. Micelle Product Picture
Figure 6. Liposomes Product Picture
Figure 7. Nanocrystals Product Picture
Figure 8. Metal Nanoparticles Product Picture
Figure 9. Others Product Picture
Figure 10. Global Central Nervous System Nanomedicines Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Central Nervous System Nanomedicines Market Share by Application: 2024 & 2031
Figure 12. Brain Tumor
Figure 13. Post Stroke Neural Repair
Figure 14. Alzheimer's Disease
Figure 15. Parkinson's Disease
Figure 16. Epilepsy
Figure 17. Central Nervous System Infection
Figure 18. Mental Illness
Figure 19. Others
Figure 20. Global Central Nervous System Nanomedicines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 21. Global Central Nervous System Nanomedicines Market Size (2020-2031) & (US$ Million)
Figure 22. Global Central Nervous System Nanomedicines Sales (2020-2031) & (Units)
Figure 23. Global Central Nervous System Nanomedicines Average Price (US$/Unit) & (2020-2031)
Figure 24. Central Nervous System Nanomedicines Report Years Considered
Figure 25. Central Nervous System Nanomedicines Sales Share by Manufacturers in 2024
Figure 26. Global Central Nervous System Nanomedicines Revenue Share by Manufacturers in 2024
Figure 27. Global 5 and 10 Largest Central Nervous System Nanomedicines Players: Market Share by Revenue in Central Nervous System Nanomedicines in 2024
Figure 28. Central Nervous System Nanomedicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 29. Global Central Nervous System Nanomedicines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 30. North America Central Nervous System Nanomedicines Sales Market Share by Country (2020-2031)
Figure 31. North America Central Nervous System Nanomedicines Revenue Market Share by Country (2020-2031)
Figure 32. United States Central Nervous System Nanomedicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Canada Central Nervous System Nanomedicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Europe Central Nervous System Nanomedicines Sales Market Share by Country (2020-2031)
Figure 35. Europe Central Nervous System Nanomedicines Revenue Market Share by Country (2020-2031)
Figure 36. Germany Central Nervous System Nanomedicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. France Central Nervous System Nanomedicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. U.K. Central Nervous System Nanomedicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Italy Central Nervous System Nanomedicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Russia Central Nervous System Nanomedicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Asia Pacific Central Nervous System Nanomedicines Sales Market Share by Region (2020-2031)
Figure 42. Asia Pacific Central Nervous System Nanomedicines Revenue Market Share by Region (2020-2031)
Figure 43. China Central Nervous System Nanomedicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Japan Central Nervous System Nanomedicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. South Korea Central Nervous System Nanomedicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. India Central Nervous System Nanomedicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Australia Central Nervous System Nanomedicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. China Taiwan Central Nervous System Nanomedicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Southeast Asia Central Nervous System Nanomedicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Latin America Central Nervous System Nanomedicines Sales Market Share by Country (2020-2031)
Figure 51. Latin America Central Nervous System Nanomedicines Revenue Market Share by Country (2020-2031)
Figure 52. Mexico Central Nervous System Nanomedicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Brazil Central Nervous System Nanomedicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Argentina Central Nervous System Nanomedicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Colombia Central Nervous System Nanomedicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Middle East and Africa Central Nervous System Nanomedicines Sales Market Share by Country (2020-2031)
Figure 57. Middle East and Africa Central Nervous System Nanomedicines Revenue Market Share by Country (2020-2031)
Figure 58. Turkey Central Nervous System Nanomedicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Saudi Arabia Central Nervous System Nanomedicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. UAE Central Nervous System Nanomedicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 61. Global Sales Market Share of Central Nervous System Nanomedicines by Type (2020-2031)
Figure 62. Global Revenue Market Share of Central Nervous System Nanomedicines by Type (2020-2031)
Figure 63. Global Central Nervous System Nanomedicines Price (US$/Unit) by Type (2020-2031)
Figure 64. Global Sales Market Share of Central Nervous System Nanomedicines by Application (2020-2031)
Figure 65. Global Revenue Market Share of Central Nervous System Nanomedicines by Application (2020-2031)
Figure 66. Global Central Nervous System Nanomedicines Price (US$/Unit) by Application (2020-2031)
Figure 67. Central Nervous System Nanomedicines Value Chain
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
